USANA HEALTH SCIENCES INC
For the period ended Oct 22, 2024. Filed Oct 22, 2024.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 22, 2024 · Filed Oct 22, 2024
USNA$13.63-1.7%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except per share data)
(in thousands, except per share data)
| Quarter Ended | ||
|---|---|---|
| September 28,2024 | September 30,2023 | |
| Net sales | $200,221 | $213,365 |
| Cost of sales | 39,257 | 42,529 |
| Gross profit | 160,964 | 170,836 |
| Operating expenses: | ||
| Associate incentives | 84,068 | 89,926 |
| Selling, general and administrative | 61,295 | 63,303 |
| Total operating expenses | 145,363 | 153,229 |
| Earnings from operations | 15,601 | 17,607 |
| Other income (expense): | ||
| Interest income | 3,142 | 2,733 |
| Interest expense | (49) | (43) |
| Other, net | (86) | 234 |
| Other income (expense), net | 3,007 | 2,924 |
| Earnings before income taxes | 18,608 | 20,531 |
| Income taxes | 8,001 | 9,184 |
| Net earnings | $10,607 | $11,347 |
| Earnings per common share | ||
| Basic | $0.56 | $0.59 |
| Diluted | $0.56 | $0.59 |
| Weighted average common shares outstanding | ||
| Basic | 19,078 | 19,245 |
| Diluted | 19,083 | 19,372 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.